Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kozak, E. A.
Right arrow Articles by Brath, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kozak, E. A.
Right arrow Articles by Brath, L. K.
(Chest. 1994;106:703-705.)
© 1994 American College of Chest Physicians

Do "Screening" Coagulation Tests Predict Bleeding in Patients Undergoing Fiberoptic Bronchoscopy With Biopsy?

Elizabeth A. Kozak M.D.1 and Lisa K. Brath M.D.2

1 From the Medical College of Virginia; and the McGuire Veterans Administration Medical Center, Richmond, Va.
2 From the McGuire Veterans Administration Medical Center, Richmond, Va.

Objective: To determine if preprocedure coagulation testing predicts bleeding in patients undergoing flexible fiberoptic bronchoscopy (FOB) with biopsy.

Design: Retrospective chart review.

Setting: Southeastern, urban Veteran Affairs Medical Center.

Measurements and main results: Two hundred seventy-four patient charts representing 305 FOB with biopsy were reviewed for clinical predictors of bleeding, prebronchoscopy laboratory abnormalities, and incidence of bleeding complications. Thirty-five patients bled, and 3 had abnormal results of coagulation studies. Normal results of coagulation studies and no clinical risk factors were noted in 68 percent of patients who bled.

Conclusion: Patients undergoing flexible FOB with biopsy do not benefit from preprocedure coagulation testing.

Key Words: bleeding • bronchoscopy • screening

Submitted on August 27, 1993
Accepted on March 15, 1994




This article has been cited by other articles:


Home page
 ThoraxHome page
A Manhire, M Charig, C Clelland, F Gleeson, R Miller, H Moss, K Pointon, C Richardson, and E Sawicka
Guidelines for radiologically guided lung biopsy
Thorax, November 1, 2003; 58(11): 920 - 936.
[Full Text] [PDF]

Home page
 ThoraxHome page
D. Mitchell
British Thoracic Society guidelines on diagnostic flexible bronchoscopy
Thorax, February 1, 2001; 56(90001): 1i - 21.
[Full Text]

Home page
 ChestHome page
C. S. Kitchens
A Stuck PigEven on WarfarinDoesn't Always Bleed
Chest, June 1, 1999; 115(6): 1492 - 1493.
[Full Text] [PDF]

Home page
 ChestHome page
D. A. Brickey and D. P. Lawlor
Transbronchial Biopsy in the Presence of Profound Elevation of the International Normalized Ratio
Chest, June 1, 1999; 115(6): 1667 - 1671.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.